PAM
WX

Princeton Alpha Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Princeton Alpha Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,620
Closed -$257K – 1002
2014
Q4 		$257K Buy
+7,620
New +$269K 0.07% 496

Other funds holding WX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Princeton Alpha Management's WX Position: Q1 2015 in Review

Princeton Alpha Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2015, closing a stake of 7,620 shares — an estimated $257K sold.

Princeton Alpha Management first reported a position in WX in Q4 2014 and held it in 1 quarter. The position peaked at $257K in Q4 2014. 147 funds tracked by Wall St. Rank hold WX as of Q1 2015.

  • Princeton Alpha Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2015 after selling out during the quarter.
  • Princeton Alpha Management sold 7,620 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2015, an estimated $257K.
  • Princeton Alpha Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2014 and held it in 1 quarter.
  • Princeton Alpha Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $257K in Q4 2014.
  • 147 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2015.

Based on Princeton Alpha Management's 13F filing for Q1 2015, filed 8 May 2015.